All

What are you looking for?

All
Projects
Results
Organizations

Quick search

  • Projects supported by TA ČR
  • Excellent projects
  • Projects with the highest public support
  • Current projects

Smart search

  • That is how I find a specific +word
  • That is how I leave the -word out of the results
  • “That is how I can find the whole phrase”

Tau oligomers in sera of patients with Alzheimer’s disease and aged controls

The result's identifiers

  • Result code in IS VaVaI

    <a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00023752%3A_____%2F17%3A43915413" target="_blank" >RIV/00023752:_____/17:43915413 - isvavai.cz</a>

  • Alternative codes found

    RIV/00216208:11120/17:43913180

  • Result on the web

    <a href="http://content.iospress.com/articles/journal-of-alzheimers-disease/jad170048" target="_blank" >http://content.iospress.com/articles/journal-of-alzheimers-disease/jad170048</a>

  • DOI - Digital Object Identifier

    <a href="http://dx.doi.org/10.3233/JAD-170048" target="_blank" >10.3233/JAD-170048</a>

Alternative languages

  • Result language

    angličtina

  • Original language name

    Tau oligomers in sera of patients with Alzheimer’s disease and aged controls

  • Original language description

    Although tau protein was long regarded as an intracellular protein with several functions inside the cell, new evidence has shown tau secretion into the extracellular space. The active secretion of tau could be a physiological response of neurons to increased intracellular amounts of tau during the progression of tau pathology. We looked for potential differences in the serum levels of toxic tau oligomers in regards to cognitive impairment of subjects. We detected tau oligomers in the serum of Alzheimer’s disease (AD) patients, but they were also present to some extent in the serum of healthy older subjects where the levels positively correlated with aging (Spearman r = 0.26, p = 0.016). On the contrary, we found lower levels of tau oligomers in the serum of mild cognitive impairment (MCI) (p = 0.033) and MCI-AD (p = 0.006) patients. These results could suggest that clearance of extracellular tau proteins takes place, in part, in the periphery. In the case of MCI patients, the lower levels of tau oligomers could be the result of impaired clearance of tau protein from interstitium to blood and consequent accumulation of tau aggregates in the brain.

  • Czech name

  • Czech description

Classification

  • Type

    J<sub>imp</sub> - Article in a specialist periodical, which is included in the Web of Science database

  • CEP classification

  • OECD FORD branch

    30103 - Neurosciences (including psychophysiology)

Result continuities

  • Project

    Result was created during the realization of more than one project. More information in the Projects tab.

  • Continuities

    P - Projekt vyzkumu a vyvoje financovany z verejnych zdroju (s odkazem do CEP)

Others

  • Publication year

    2017

  • Confidentiality

    S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Data specific for result type

  • Name of the periodical

    Journal of Alzheimer´s Disease

  • ISSN

    1387-2877

  • e-ISSN

  • Volume of the periodical

    58

  • Issue of the periodical within the volume

    2

  • Country of publishing house

    NL - THE KINGDOM OF THE NETHERLANDS

  • Number of pages

    8

  • Pages from-to

    471-478

  • UT code for WoS article

    000402994400015

  • EID of the result in the Scopus database

    2-s2.0-85019188326